Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Global Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines that treat disease and improve human health.
Visit the NIBR newsroom to learn about events going on within NIBR and read in-depth stories about how NIBR is addressing the changing needs of patients worldwide.
© 2013 Novartis AG Terms of usePrivacy policy Sitemap
